Clinical Value of Serum Cancer Antigen 19-9 as a Tumor Screening Marker among Healthy Individuals

Authors

  • Prodip Kumar Biswas Associate Professor of Medicine, Dhaka Medical College, Dhaka
  • Md Hafiz Sardar Professor of Medicine, Dhaka Medical College, Dhaka
  • Gopal Chandra Saha Assistant Professor, Department of Radiology and Imaging, Institute of Child and Mother Health, Dhaka
  • Mohammed Shahadat Hossain Assistant Professor of Medicine, OSD, DGHS. Attached to Faridpur Medical College, Faridpur
  • Mohammad Motlabur Rahman Associate Professor of Medicine, Dhaka Medical College, Dhaka
  • Mostofa Kamal Chowdhury Assistant Professor, Department of Palliative Medicine, Centre for Palliative Care, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Tushit Paul Post graduate trainee, Department of Medicine, Dhaka Medical College, Hospital, Dhaka

DOI:

https://doi.org/10.3329/jom.v20i2.42009

Keywords:

Tumor marker, CA 19-9, Malignancy

Abstract

Background: Serum tumor markers are convenient, non-invasive, acceptable to patients and play an important role as an ancillary tumor diagnostic tool. CA 19-9 has become a common tumor marker, specific for digestive system tumors. The study was carried out to determine the value of CA 19-9 as a tumor screening marker among healthy individuals.

Materials and Methods: This study had been carried in Dhaka Medical college Hospital from January 2016 to January 2018. The serum CA 19-9 level was detected using a microsome luminescence method. Individuals with high CA 19-9 levels underwent further examination, including routine fecal testing, thoracic and abdominal computed tomography (CT) scan, gastroscopy, and colonoscopy. These individuals had regular follow-up examinations.

Results: Over a 3-year period, the serum CA19-9 levels of 960 healthy individuals were estimated. The CA 19-9 level of 15 individuals was positive (positive rate: 1.56%), including 7 men (7/699; 1.001%) and 8 women (8/261; 3.06%). There was a significant difference between males and females (p<0.01), The overall tumor detection rate was 0.72% (7/960) including 6/699 men (0.85%) and 1/261 women (0.38%).

Conclusion: Therefore, elevated CA 19-9 level can be used to assist in the diagnosis malignancy.

J MEDICINE JUL 2019; 20 (2) : 92-94

Downloads

Download data is not yet available.
Abstract
408
PDF
462

Downloads

Published

2019-06-27

How to Cite

Biswas, P. K., Sardar, M. H., Saha, G. C., Hossain, M. S., Rahman, M. M., Chowdhury, M. K., & Paul, T. (2019). Clinical Value of Serum Cancer Antigen 19-9 as a Tumor Screening Marker among Healthy Individuals. Journal of Medicine, 20(2), 92–94. https://doi.org/10.3329/jom.v20i2.42009

Issue

Vol. 20 No. 2 (2019)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).